138 related articles for article (PubMed ID: 10448019)
1. Metabolic treatment of myocardial ischaemia.
Ferrari R
Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
[No Abstract] [Full Text] [Related]
2. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
Labrid C
Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
[TBL] [Abstract][Full Text] [Related]
3. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
Eliseev OM
Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
[No Abstract] [Full Text] [Related]
4. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
[TBL] [Abstract][Full Text] [Related]
5. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
O'Meara E; McMurray JJ
Heart; 2005 Feb; 91(2):131-2. PubMed ID: 15657211
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological preconditioning as a way of the increasing of myocytes resistance to ischemia].
Wilczewski P; Poloński L
Wiad Lek; 2000; 53(7-8):449-53. PubMed ID: 11070768
[TBL] [Abstract][Full Text] [Related]
7. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
[TBL] [Abstract][Full Text] [Related]
8. Can metabolic manipulation reverse myocardial dysfunction?
Cokkinos DV
Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
[No Abstract] [Full Text] [Related]
9. Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Rizzon P; Iliceto S; Marangelli V
Cardiologia; 1995 Oct; 40(10):717-20. PubMed ID: 8819732
[No Abstract] [Full Text] [Related]
10. Metabolic therapy for heart failure.
Essop MF; Opie LH
Eur Heart J; 2004 Oct; 25(20):1765-8. PubMed ID: 15474689
[No Abstract] [Full Text] [Related]
11. [Therapeutic application of myocardial cytoprotection].
Ribeiro C
Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
[No Abstract] [Full Text] [Related]
12. Role of trimetazidine in management of ischemic cardiomyopathy.
Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
[TBL] [Abstract][Full Text] [Related]
13. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
Stanley WC; Sabbah HN
Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
[No Abstract] [Full Text] [Related]
14. Cardioprotective effects of trimetazidine and a combination of succinic and malic acids in acute myocardial ischemia.
Khazanov VA; Kiseliova AA; Vasiliev KY; Chernyschova GA
Bull Exp Biol Med; 2008 Aug; 146(2):218-22. PubMed ID: 19145322
[TBL] [Abstract][Full Text] [Related]
15. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Stanley WC; Marzilli M
Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
[TBL] [Abstract][Full Text] [Related]
16. Metabolic therapy for the diabetic patients with ischaemic heart disease.
Rosano GM; Vitale C; Volterrani M; Fini M
Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
[TBL] [Abstract][Full Text] [Related]
18. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
19. Angina, myocardial hibernation and trimetazidine.
Jackson G
Int J Clin Pract; 1997 Sep; 51(6):347. PubMed ID: 9489058
[No Abstract] [Full Text] [Related]
20. Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia.
Monteiro P; Duarte AI; Gonçalves LM; Moreno A; Providência LA
Eur J Pharmacol; 2004 Oct; 503(1-3):123-8. PubMed ID: 15496306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]